Is VDR useful for menopause?

Based on the provided context, there is no direct information about VDR (Vitamin D Receptor) and menopause. The context covers other genetic variants (MTHFR, CYP1A2, HFE) and biomarkers (HbA1c, CGM, microbiome), but not VDR. In general, VDR polymorphisms (e.g., FokI, BsmI) are studied for their influence on vitamin D metabolism and bone density, which are relevant to postmenopausal osteoporosis. However, the evidence is mixed: some association studies show moderate effects, but there are no robust RCTs proving clinical utility of VDR testing for menopause management. Consumer DNA tests may include VDR, but results alone are insufficient for treatment decisions. Blood vitamin D levels and DXA scans are more reliable. Therefore, the usefulness of VDR for menopause is currently rated as 'mixed' to 'mechanistic'. Supplementation should be based on blood values and medical advice, not solely on genetic variants.